Tom Powles: TAR-210 releases Erdafitinib slowly into the bladder by a novel release system

Tom Powles, Director of Barts Cancer Centre, shared on Twitter:

”Something NEW. TAR-210 releases Erdafitinib slowly into the bladder by a novel release system. In BCG refractory FGFR selected High risk NMIBC 82-87% of patients were recurrent free at 1st cut off in the 2 cohort. This could have a major impact in NMIBC and MIBC.”

Source: Tom Powles/Twitter